Abstract
N-acetyl cysteine (NAC) is an antioxidant that possesses anti-inflammatory activities in tissues. In the field of dentistry, NAC was demonstrated to prevent the expression of LPS-induced inflammatory mediators in phagocytic cells and gingival fibroblasts during the inflammatory process, but the effect of NAC on oral pathogens has been rarely studied. Here, we examined the effect of NAC against planktonic and biofilm cells of Prevotella intermedia, a major oral pathogen. NAC showed antibacterial activity against the planktonic P. intermedia with MIC value of 3 mg/ml and significantly decreased biofilm formation by the bacterium even at sub MIC. NAC did not affect the antibiotic susceptibility of planktonic P. intermedia, showing indifference (fractional inhibitory concentration index of 0.5–4) results against the bacterium in combination with ampicillin, ciprofloxacin, tetracycline or metronidazole. On the other hand, viability of the pre-established bacterial biofilm exposed to the antibiotics except metronidazole was increased in the presence of NAC. Collectively, NAC may be used for prevention of the biofilm formation by P. intermedia rather than eradication of the pre-established bacterial biofilm. Further studies are required to explore antibacterial and anti-biofilm activity of NAC against mixed population of oral bacteria and its modulatory effect on antibiotics used for oral infectious diseases.
Similar content being viewed by others
References
Albesa, I., Becerra, M.C., Battan, P.C., and Paez, P.L. 2004. Oxidative stress involved in the antibacterial action of different antibiotics. Biochem. Biophys. Res. Commun. 317, 605–609.
Ali, K.F. 2014. Estimation and evaluation of the effect of pH on ciprofloxacin in drug formulations. J. Chem. Pharm. Res. 6, 910–916.
Alkawareek, M.Y., Algwari, Q.T., Laverty, G., Gorman, S.P., Graham, W.G., O’Connell, D., and Gilmore, B.F. 2012. Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure nonthermal plasma. PLoS One 7, e44289.
Andrés, M.T., Chung, W.O., Roberts, M.C., and Fierro, J.F. 1998. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob. Agents Chemother. 42, 3022–3023.
Ashimoto, A., Chen, C., Bakker, I., and Slots, J. 1996. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol. Immunol. 11, 266–273.
Barbee, L.A., Soge, O.O., Holmes, K.K., and Golden, M.R. 2014. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. J. Antimicrob. Chemother. 69, 1572–1578.
Becerra, M.C. and Albesa, I. 2002. Oxidative stress induced by ciprofloxacin in Staphylococcus aureus. Biochem. Biophys. Res. Commun. 297, 1003–1007.
Bolivar, I., Whiteson, K., Stadelmann, B., Baratti-Mayer, D., Gizard, Y., Mombelli, A., Pittet, D., and Schrenzel, J. 2012. Bacterial diversity in oral samples of children in Niger with acute noma, acute necrotizing gingivitis, and healthy controls. PLoS Negl. Trop. Dis. 6, e1556.
Brook, I. and Frazier, E.H. 2003. Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis. Chest 124, 832–833.
Carvalho, I., Henriques, M., and Carvalho, S. 2013. New strategies to fight bacterial adhesion. Microbial pathogens and strategies for combating them: science, technology and education In Méndez-Vilas, A. (ed.) FORMATEX 170–178.
Chong, A., Wehrly, T.D., Nair, V., Fischer, E.R., Barker, J.R., Klose, K.E., and Celli, J. 2008. The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect. Immun. 76, 5488–5499.
CLSI. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 7th ed. Document M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
Denny, T.P., Makini, F.W., and Brumbley, S.M. 1988. Characterization of Pseudomonas solanacearum Tn5 mutants deficient in extracellular polysaccharide. Mol. Plant Microbe Interact. 1, 215–223.
Donlan, R.M. 2002. Biofilms: Microbial life on surfaces. Emerg. Infect. Dis. 8, 881–890.
Ehsani, M., Moghadamnia, A., Zahedpasha, S., Maliji, G., Haghanifar, S., Mir, S.M., and Kani, N.M. 2012. The role of prophylactic ibuprofen and N-acetylcysteine on the level of cytokines in periapical exudates and the post-treatment pain. Daru. 20, 30.
Falkler, W.A. Jr., Enwonwu, C.O., and Idigbe, E.O. 1999. Microbiological understandings and mysteries of noma (cancrum oris). Oral Dis. 5, 150–155.
Fosse, T., Madinier, I., Hannoun, L., Giraud-Morin, C., Hitzig, C., Charbit, Y., and Ourang, S. 2002. High prevalence of cfxAß-lactamase in aminopenicillin-resistant Prevotella strains isolated from periodontal pockets. Oral Microbiol. Immunol. 17, 85–88.
Gokcimen, A., Cim, A., Tola, H.T., Bayram, D., Kocak, A., Ozgüner, F., and Ayata, A. 2007. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity. Hum. Exp. Toxicol. 26, 519–525.
Gomes, B.P., Drucker, D.B., and Lilley, J.D. 1994. Associations of specific bacteria with some endodontic signs and symptoms. Int. Endod. J. 27, 291–298.
Gomes, B.P., Lilley, J.D., and Drucker, D.B. 1996. Associations of endodontic symptoms and signs with particular combinations of specific bacteria. Int. Endod. J. 29, 69–75.
Goswami, M. and Jawali, N. 2007. Glutathione-mediated augmentation of ß-lactam antibacterial activity against Escherichia coli. J. Antimicrob. Chemother. 60, 184–185.
Goswami, M. and Jawali, N. 2010. N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility. Antimicrob. Agents Chemother. 54, 3529–3530.
Goswami, M., Mangoli, S.H., and Jawali, N. 2006. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob. Agents Chemother. 50, 949–954.
Goswami, M., Mangoli, S.H., and Jawali, N. 2007. Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli. Antimicrob. Agents Chemother. 51, 1119–1122.
Honma, K., Mishima, E., Inagaki, S., and Sharma, A. 2009. The OxyR homologue in Tannerella forsythia regulates expression of oxidative stress responses and biofilm formation. Microbiology 155, 1912–1922.
Hsu, H.Y. and Wen, M.H. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277, 22131–22139.
Jacinto, R.C., Gomes, B.P., Ferraz, C.C., Zaia, A.A., and Filho, F.J. 2003. Microbiological analysis of infected root canals from symptomatic and asymptomatic teeth with periapical periodontitis and the antimicrobial susceptibility of some isolated anaerobic bacteria. Oral Microbiol. Immunol. 18, 285–292.
Kamberi, M., Tsutsumi, K., Kotegawa, T., Kawano, K., Nakamura, K., Niki, Y., and Nakano, S. 1999. Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. Antimicrob. Agents Chemother. 43, 525–529.
Kaplan, M., Atakan, I.H., Aydogdu, N., Aktoz, T., Ozpuyan, F., Seren, G., Tokuç, B., and Inci, O. 2008. Influence of N-acetylcysteine on renal toxicity of cadmium in rats. Pediatr. Nephrol. 23, 233–241.
Kim, D.Y., Jun, J.H., Lee, H.L., Woo, K.M., Ryoo, H.M., Kim, G.S., Baek, J.H., and Han, S.B. 2007. N-acetylcysteine prevents LPSinduced pro-inflammatory cytokines and MMP2 production in gingival fibroblasts. Arch. Pharm. Res. 30, 1283–1292.
Koussémon, M., Combet-Blanc, Y., and Ollivier, B. 2003. Glucose fermentation by Propionibacterium microaerophilum: effect of pH on metabolism and bioenergetic. Curr. Microbiol. 46, 141–145.
Lee, N.K., Choi, Y.G., Baik, J.Y., Han, S.Y., Jeong, D.W., Bae, Y.S., Kim, N., and Lee, S.Y. 2005. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852–859.
Leke, N., Grenier, D., Goldner, M., and Mayrand, D. 1999. Effects of hydrogen peroxide on growth and selected properties of Porphyromonas gingivalis. FEMS Microbiol. Lett. 174, 347–353.
Lemos, J.A., Abranches, J., Koo, H., Marquis, R.E., and Burne, R.A. 2010. Protocols to study the physiology of oral biofilms. Methods Mol. Biol. 666, 87–102.
Maeda, N., Okamoto, M., Kondo, K., Ishikawa, H., Osada, R., Tsurumoto, A., and Fujita H. 1998. Incidence of Prevotella intermedia and Prevotella nigrescens in periodontal health and disease. Microbiol. Immunol. 42, 583–539.
Marchese, A., Bozzolasco, M., Gualco, L., Debbia, E.A., Schito, G.C., and Schito, A.M. 2003. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int. J. Antimicrob. Agents 22, 95–100.
Mombelli, A., Schmid, B., Rutar, A., and Lang, N.P. 2000. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease. J. Periodontol. 71, 14–21.
Moon, J.H., Kim, C., Lee, H.S., Kim, S.W., and Lee, J.Y. 2013. Antibacterial and antibiofilm effects of iron chelators against Prevotella intermedia. J. Med. Microbiol. 62, 1307–1316.
Moon, J.H., Park, J.H., and Lee, J.Y. 2011. Antibacterial action of polyphosphate on Porphyromonas gingivalis. Antimicrob. Agents. Chemother. 55, 806–812.
Olofsson, A.C., Hermansson, M., and Elwing, H. 2003. N-acetyl- L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl. Environ. Microbiol. 69, 4814–4822.
Pérez-Giraldo, C., Rodríguez-Benito, A., Morán, F.J., Hurtado, C., Blanco, M.T., and Gómez-García, A.C. 1997. Influence of Nacetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J. Antimicrob. Chemother. 39, 643–646.
Quah, S.Y., Wu, S., Lui, J.N., Sum, C.P., and Tan, K.S. 2012. Nacetylcysteine inhibits growth and eradicates biofilm of Enterococcus faecalis. J. Endod. 38, 81–85.
Rao, M.S., Pintado, J., Stevens, W.F., and Guyot, J.P. 2004. Kinetic growth parameters of different amylolytic and non-amylolytic Lactobacillus strains under various salt and pH conditions. Bioresour. Technol. 94, 331–337.
Rôças, I.N., Siqueira, J.F. Jr., and Santos, K.R. 2004. Association of Enterococcus faecalis with different forms of periradicular diseases. J. Endod. 30, 315–320.
Ross, D. 1988. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione- dependent protection. Pharmacol. Ther. 37, 231–249.
Scannapieco, F.A., Papandonatos, G.D., and Dunford, R.G. 1998. Associations between oral conditions and respiratory disease in a national sample survey population. Ann. Periodontol. 3, 251–256.
Schwandt, L.Q., Van Weissenbruch, R., Stokroos, I., Van der Mei, H.C., Busscher, H.J., and Albers, F.W. 2004. Prevention of biofilm formation by dairy products and Nacetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 124, 726–731.
Shinzato, T. and Saito, A. 1994. A mechanism of pathogenicity of “Streptococcus milleri group” in pulmonary infection: synergy with an anaerobe. J. Med. Microbiol. 40, 118–123.
Simmons, W.L. and Dybvig, K. 2007. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect. Immun. 75, 3696–3699.
Stey, C., Steurer, J., Bachmann, S., Medici, T.C., and Tramèr, M.R. 2000. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur. Respir. J. 16, 253–262.
Takahashi, N., Ishihara, K., Kimizuka, R., Okuda, K., and Kato, T. 2006. The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm. Oral Microbiol. Immunol. 21, 366–371.
Takahashi, N., Saito, K., Schachtele, C.F., and Yamada, T. 1997. Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum. Oral Microbiol. Immunol. 12, 323–328.
Takahashi, N. and Schachtele, C.F. 1990. Effect of pH on the growth and proteolytic activity of Porphyromonas gingivaiis and Bacteroides intermedius. J. Dent. Res. 69, 1266–1269.
Takahashi, N. and Yamada, T. 2000. Glucose metabolism by Prevotella intermedia and Prevotella nigrescens. Oral Microbiol. Immunol. 15, 188–195.
Toker, H., Ozdemir, H., Eren, K., Ozer, H., and Sahin, G. 2009. N-acetylcysteine, a thiol antioxidant, decreases alveolar bone loss in experimental periodontitis in rats. J. Periodontol. 80, 672–678.
Ulrich, M., Beer, I., Braitmaier, P., Dierkes, M., Kummer, F., Krismer, B., Schumacher, U., Gräpler-Mainka, U., Riethmüller, J., Jensen, P.Ø., et al. 2010. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis. Thorax. 65, 978–984.
Vercelino, R., Tieppo, J., Dias, A.S., Marroni, C.A., Garcia, E., Meurer, L., Picada, J.N., and Marroni, N.P. 2008. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin. Pharmacol. Toxicol. 102, 370–376.
Zafarullah, M., Li, W.Q., Sylvester, J., and Ahmad, M. 2003. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 60, 6–20.
Zhao, T. and Liu, Y. 2010. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 10, 140.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moon, JH., Jang, EY., Shim, K.S. et al. In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia . J Microbiol. 53, 321–329 (2015). https://doi.org/10.1007/s12275-015-4500-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-015-4500-2